Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2002
Synthesis and structure-activity relationships of oxime neurokinin antagonists: discovery of potent arylamides
Neng Yang Shih, Margaret Albanese, John C Anthes, et al.
European Journal of Pharmacology
|
May 24, 2008
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor
Leah Aluisio, Brian Lord, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2007
Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors
John M Keith, Leslie A Gomez, Ronald L Wolin, et al.
ACS Medicinal Chemistry Letters
|
March 21, 2019
1<i>H</i>-Pyrrolo[3,2-<i>b</i>]pyridine GluN2B-Selective Negative Allosteric Modulators
Christa C Chrovian, Akinola Soyode-Johnson, Jessica L Wall, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 3, 2009
Novel imidazole-based histamine H3 antagonists
Jill A Jablonowski, Kiev S Ly, Michael Bogenstaetter, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 14, 2009
Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat
Christine Dugovic, Jonathan E Shelton, Leah E Aluisio, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 17, 2010
Indole- and benzothiophene-based histamine H3 antagonists
Alejandro Santillan, Kelly J McClure, Brett D Allison, et al.
ACS Medicinal Chemistry Letters
|
March 21, 2019
Discovery of Imidazo[1,2-<i>a</i>]pyrazines and Pyrazolo[1,5-<i>c</i>]pyrimidines as TARP γ-8 Selective AMPAR Negative Modulators
Brad M Savall, Dongpei Wu, Devin M Swanson, et al.
British Journal of Pharmacology
|
October 7, 2004
Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist
A J Barbier, C Berridge, C Dugovic, et al.
Nuclear Medicine and Biology
|
August 29, 2006
Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand
Anu J Airaksinen, Jill A Jablonowski, Margreet van der Mey, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2002
Synthesis and structure-activity relationships of oxime neurokinin antagonists: discovery of potent arylamides
Neng Yang Shih, Margaret Albanese, John C Anthes, et al.
European Journal of Pharmacology
|
May 24, 2008
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor
Leah Aluisio, Brian Lord, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 24, 2007
Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors
John M Keith, Leslie A Gomez, Ronald L Wolin, et al.
ACS Medicinal Chemistry Letters
|
March 21, 2019
1<i>H</i>-Pyrrolo[3,2-<i>b</i>]pyridine GluN2B-Selective Negative Allosteric Modulators
Christa C Chrovian, Akinola Soyode-Johnson, Jessica L Wall, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 3, 2009
Novel imidazole-based histamine H3 antagonists
Jill A Jablonowski, Kiev S Ly, Michael Bogenstaetter, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 14, 2009
Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat
Christine Dugovic, Jonathan E Shelton, Leah E Aluisio, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 17, 2010
Indole- and benzothiophene-based histamine H3 antagonists
Alejandro Santillan, Kelly J McClure, Brett D Allison, et al.
ACS Medicinal Chemistry Letters
|
March 21, 2019
Discovery of Imidazo[1,2-<i>a</i>]pyrazines and Pyrazolo[1,5-<i>c</i>]pyrimidines as TARP γ-8 Selective AMPAR Negative Modulators
Brad M Savall, Dongpei Wu, Devin M Swanson, et al.
British Journal of Pharmacology
|
October 7, 2004
Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist
A J Barbier, C Berridge, C Dugovic, et al.
Nuclear Medicine and Biology
|
August 29, 2006
Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand
Anu J Airaksinen, Jill A Jablonowski, Margreet van der Mey, et al.
Page
of 10